Clinical practice. Vitiligo. [N Engl J Med. 2009] - PubMed

loading

Review Vitiligo: nonsurgical treatment options and the evidence behind their use. [J Drugs Dermatol. 2008]
Review Vitiligo: nonsurgical treatment options and the evidence behind their use.
Fenton JS, Bergstrom KG. J Drugs Dermatol. 2008 Jul; 7(7):705-11.
A rational approach to the treatment of vitiligo and other hypomelanoses. [Dermatol Clin. 2007]
A rational approach to the treatment of vitiligo and other hypomelanoses.
Hercogová J, Buggiani G, Prignano F, Lotti T. Dermatol Clin. 2007 Jul; 25(3):383-92, ix.
Review Vitiligo management update. [Skin Therapy Lett. 2000]
Review Vitiligo management update.
Westerhof W. Skin Therapy Lett. 2000; 5(6):1-2,5.
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. [Arch Dermatol. 1999]
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology.
Njoo MD, Westerhof W, Bos JD, Bossuyt PM. Arch Dermatol. 1999 Dec; 135(12):1514-21.
Review Vitiligo. [Q Med Rev. 1979]
Review Vitiligo.
Punshi SK. Q Med Rev. 1979 Oct; 30(4):1-46.

Th17 cells and activated dendritic cells are increased in vitiligo lesions. [PLoS One. 2011]
Th17 cells and activated dendritic cells are increased in vitiligo lesions.
Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M, Gilleaudeau P, Cohen JA, Krueger JG. PLoS One. 2011 Apr 25; 6(4):e18907. Epub 2011 Apr 25.
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. [Korean J Hepatol. 2011]
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK. Korean J Hepatol. 2011 Mar; 17(1):61-5.
Review Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. [Thyroid. 2010]
Review Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.
Spritz RA. Thyroid. 2010 Jul; 20(7):745-54.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Clinical practice. Vitiligo.
Clinical practice. Vitiligo.
N Engl J Med. 2009 Jan 8 ;360(2):160-9.

PubMed
Toward a genetics of cancer resistance.
Toward a genetics of cancer resistance.
Proc Natl Acad Sci U S A. 2009 Jan 20 ;106(3):859-63. Epub 2009 Jan 7 .

PubMed
TRPC6 mutations associated with focal segmental glomerulosclerosis cause constit...
TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
Am J Physiol Cell Physiol. 2009 Mar ;296(3):C558-69. Epub 2009 Jan 7 .

PubMed
Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkey...
Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.
J Virol. 2009 Mar ;83(6):2686-96. Epub 2009 Jan 7 .

PubMed
Metabolomics and its application for non-invasive embryo assessment in IVF.
Metabolomics and its application for non-invasive embryo assessment in IVF.
Mol Hum Reprod. 2008 Dec ;14(12):679-90.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed